<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04123977</url>
  </required_header>
  <id_info>
    <org_study_id>7406</org_study_id>
    <nct_id>NCT04123977</nct_id>
  </id_info>
  <brief_title>Evaluation of Patient Analgesia After Bloc Serratus</brief_title>
  <acronym>TraumaThorax</acronym>
  <official_title>Evaluation of Patient Analgesia After Bloc Serratus for the Management of Thoracic Trauma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thorax traumas are very common in severe traumatology, including road accidents, representing
      the second most frequent site (after head injury, according to the FIRST study). These
      thoracic lesions are the cause of many complications (pneumothorax, hemothorax, lung
      infections, atelectasis).

      The national recommendations recommend the use of multi-modal analgesia with the use of
      regional loco anaesthesia for pain management and prevention of respiratory complications,
      including infectious complications. The loco-regional anaesthesia of choice is thoracic
      epidural or paravertebral block, but these techniques are not without risks, and are
      contraindicated in many situations (severe head trauma, patient under curative
      anticoagulation, pelvic trauma...).

      The anterior Serratus block appears to be a quality localoregional anaesthesia in thoracic
      surgery, and a few cases in the literature have shown an interest in severe traumatology.

      The investigators perform this anterior Serratus block almost systematically in patients with
      thoracic trauma in the Hautepierre surgical intensive care unit.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective analysis of analgesia after Bloc serratus</measure>
    <time_frame>Files analysed retrospectily from January 1st, 2018 to February 28, 2019 will be examined</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Thorax Traumas</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient hospitalised in surgical intensive care or continuous trauma care with thorax
        trauma who received anterior Serratus block analgesia from January 1, 2018 to February 28,
        2019
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Adult patient (≥18 years old)

          -  Gender (Male and Female)

          -  Patient hospitalised in surgical intensive care or continuous trauma care with thorax
             trauma who received anterior Serratus block analgesia from January 1, 2018 to February
             28, 2019

          -  Patient who has given his consent to the reuse of his data for the purposes of this
             research

        Criteria for non-inclusion:

          -  Patient who has expressed opposition to participating in the study

          -  Impossibility of giving the subject informed information (difficulties in
             understanding the subject,...)

          -  Subject under the protection of justice

          -  Subject under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien POTTECHER, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julien POTTECHER, MD, PhD</last_name>
    <phone>33 3 88 12 70 95</phone>
    <email>julien.pottecher@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kevin COGNE, MD</last_name>
    <phone>33 3.88 12 61 55</phone>
    <email>kevin.cogne@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Réanimation chirurgicale_ Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien POTTECHER, MD, PhD</last_name>
      <phone>33 3 88 12 70 95</phone>
      <email>julien.pottecher@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Kevin COGNE, MD</last_name>
      <phone>33 3 88 12 61 55</phone>
      <email>kevin.cogne@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Julien POTTECHER, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kevin COGNE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul BRUNET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 3, 2019</study_first_submitted>
  <study_first_submitted_qc>October 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2019</study_first_posted>
  <last_update_submitted>October 18, 2019</last_update_submitted>
  <last_update_submitted_qc>October 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thorax trauma</keyword>
  <keyword>head injury</keyword>
  <keyword>Multi-modal analgesia</keyword>
  <keyword>Paravertebral block</keyword>
  <keyword>Thoracic epidural</keyword>
  <keyword>Serratus Block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

